Study

EORTC-26951

Phase III study of adjuvant Procarbazine, CCNU and Vincristine chemotherapy in patients with highly anaplastic oligodendroglioma (randomized)

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 13-Aug-1996
Date Step1 close: 03-Mar-2002

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 292

Protocol summary

http://clinicaltrials.gov/study/NCT00002840

NCT number

NCT00002840

Study

EORTC-26951

Phase III study of adjuvant Procarbazine, CCNU and Vincristine chemotherapy in patients with highly anaplastic oligodendroglioma (randomized)

Study documentation Back to result

Research Projects

RP-1626

Predictors of quality of life ratings from patients with primary brain tumors: the role of self-awareness and cognitive functioning